Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Sep;107(1):233–239. doi: 10.1111/j.1476-5381.1992.tb14492.x

Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.

N M Barnes 1, C H Cheng 1, B Costall 1, J Ge 1, R J Naylor 1
PMCID: PMC1907621  PMID: 1384906

Abstract

1. The ability of various anxiolytic and potential anxiolytic agents to modify 5-hydroxytryptamine (5-HT) release in the frontal cortex of the rat was assessed by the microdialysis technique. 2. The benzodiazepine receptor agonist, diazepam (2.5 mg kg-1, i.p.), the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT, 0.32 mg kg-1, s.c.) and the 5-HT1A receptor partial agonist buspirone (4.0 mg kg-1, i.p.) maximally reduced extracellular levels of 5-HT in the rat frontal cortex by approximately 50-60%, 70-80% and 30-40%, respectively. 3. (R)-zacopride (1.0-100 micrograms kg-1, i.p.) dose-dependently reduced extracellular levels of 5-HT in the rat frontal cortex (approximately 80% maximal reduction) whereas the other 5-HT3 receptor antagonists ondansetron (10 micrograms kg-1, i.p.) and (S)-zacopride (10-100 micrograms kg-1, i.p.) were ineffective. 4. In contrast to (S)-zacopride (100 nM; administered via the microdialysis probe), (R)-zacopride (1.0-100 nM; administered via the microdialysis probe) induced a concentration-dependent reduction in extracellular levels of 5-HT in the rat frontal cortex (approximately 70% maximal reduction). 5. In contrast to ondansetron (100 micrograms kg-1, i.p.), (S)-zacopride (10-100 micrograms kg-1, i.p.) dose-dependently reversed the (R)-zacopride (10 micrograms kg-1, i.p.) induced reduction in extracellular levels of 5-HT in the rat frontal cortex. The highest dose of (S)-zacopride (100 micrograms kg-1, i.p.) completely prevented the (R)-zacopride response.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
233

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auerbach S. B., Minzenberg M. J., Wilkinson L. O. Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release. Brain Res. 1989 Oct 16;499(2):281–290. doi: 10.1016/0006-8993(89)90776-2. [DOI] [PubMed] [Google Scholar]
  2. Barnes J. M., Barnes N. M., Champaneria S., Costall B., Naylor R. J. Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat. Neuropharmacology. 1990 Nov;29(11):1037–1045. doi: 10.1016/0028-3908(90)90110-d. [DOI] [PubMed] [Google Scholar]
  3. Barnes J. M., Barnes N. M., Cooper S. J. Behavioural pharmacology of 5-HT3 receptor ligands. Neurosci Biobehav Rev. 1992 Spring;16(1):107–113. doi: 10.1016/s0149-7634(05)80057-0. [DOI] [PubMed] [Google Scholar]
  4. Barnes J. M., Barnes N. M., Costall B., Domeney A. M., Johnson D. N., Kelly M. E., Munson H. R., Naylor R. J., Young R. The differential activities of R (+)- and S(-)-zacopride as 5-HT3 receptor antagonists. Pharmacol Biochem Behav. 1990 Dec;37(4):717–727. doi: 10.1016/0091-3057(90)90554-u. [DOI] [PubMed] [Google Scholar]
  5. Baxter G. S., Craig D. A., Clarke D. E. 5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae. Naunyn Schmiedebergs Arch Pharmacol. 1991 May;343(5):439–446. doi: 10.1007/BF00169544. [DOI] [PubMed] [Google Scholar]
  6. Butler A., Hill J. M., Ireland S. J., Jordan C. C., Tyers M. B. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol. 1988 Jun;94(2):397–412. doi: 10.1111/j.1476-5381.1988.tb11542.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carboni E., Di Chiara G. Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience. 1989;32(3):637–645. doi: 10.1016/0306-4522(89)90285-6. [DOI] [PubMed] [Google Scholar]
  8. Costall B., Naylor R. J., Tyers M. B. The psychopharmacology of 5-HT3 receptors. Pharmacol Ther. 1990;47(2):181–202. doi: 10.1016/0163-7258(90)90086-h. [DOI] [PubMed] [Google Scholar]
  9. Eglen R. M., Swank S. R., Walsh L. K., Whiting R. L. Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro. Br J Pharmacol. 1990 Nov;101(3):513–520. doi: 10.1111/j.1476-5381.1990.tb14113.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hutson P. H., Sarna G. S., O'Connell M. T., Curzon G. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci Lett. 1989 May 22;100(1-3):276–280. doi: 10.1016/0304-3940(89)90698-8. [DOI] [PubMed] [Google Scholar]
  11. Iversen S. D. 5-HT and anxiety. Neuropharmacology. 1984 Dec;23(12B):1553–1560. doi: 10.1016/0028-3908(84)90099-6. [DOI] [PubMed] [Google Scholar]
  12. Kidd E., Bouchelet de Vendegies I., Levy J. C., Hamon M., Gozlan H. The potent 5-HT3 receptor antagonist (R)-zacopride labels an additional high affinity site in the central nervous system. Eur J Pharmacol. 1992 Jan 28;211(1):133–136. doi: 10.1016/0014-2999(92)90276-a. [DOI] [PubMed] [Google Scholar]
  13. Pei Q., Zetterström T., Fillenz M. Both systemic and local administration of benzodiazepine agonists inhibit the in vivo release of 5-HT from ventral hippocampus. Neuropharmacology. 1989 Oct;28(10):1061–1066. doi: 10.1016/0028-3908(89)90118-4. [DOI] [PubMed] [Google Scholar]
  14. Perry K. W., Fuller R. W. Determination of brain concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin by liquid chromatography with electrochemical detection. Biochem Pharmacol. 1989 Oct 1;38(19):3169–3173. doi: 10.1016/0006-2952(89)90609-6. [DOI] [PubMed] [Google Scholar]
  15. Sharp T., Bramwell S. R., Grahame-Smith D. G. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol. 1989 Feb;96(2):283–290. doi: 10.1111/j.1476-5381.1989.tb11815.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stein L., Belluzzi J. D., Wise C. D. Benzodiazepines: behavioral and neurochemical mechanisms. Am J Psychiatry. 1977 Jun;134(6):665–669. doi: 10.1176/ajp.134.6.665. [DOI] [PubMed] [Google Scholar]
  17. Young R., Johnson D. N. Anxiolytic-like activity of R(+)- and S(-)-zacopride in mice. Eur J Pharmacol. 1991 Aug 29;201(2-3):151–155. doi: 10.1016/0014-2999(91)90338-q. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES